Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases

Background Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. Aim To investigate the delta values between expiratory and inspiratory resista...

Full description

Saved in:
Bibliographic Details
Published inClinical physiology and functional imaging Vol. 44; no. 6; pp. 426 - 435
Main Authors Nasr, Abir, Papapostolou, Georgia, Jarenbäck, Linnea, Romberg, Kerstin, Tunsäter, Alf, Ankerst, Jaro, Bjermer, Leif, Tufvesson, Ellen
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2024
Subjects
Online AccessGet full text
ISSN1475-0961
1475-097X
1475-097X
DOI10.1111/cpf.12895

Cover

Loading…
Abstract Background Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. Aim To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases. Methods Four hundred and seventy‐one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered. Results Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5–R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5–R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = −0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms. Conclusion EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
AbstractList Background Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. Aim To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases. Methods Four hundred and seventy‐one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered. Results Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5–R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5–R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = −0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms. Conclusion EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
Background: Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. Aim: To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases. Methods: Four hundred and seventy-one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered. Results: Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5–R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5–R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = −0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms. Conclusion: EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases. Four hundred and seventy-one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered. Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5-R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5-R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = -0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms. EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
Background: Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases. Aim: To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases. Methods: Four hundred and seventy-one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered. Results: Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5–R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5–R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = −0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms. Conclusion: EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
BackgroundExpiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases.AimTo investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases.MethodsFour hundred and seventy‐one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered.ResultsPatients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5–R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5–R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = −0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms.ConclusionEFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases.BACKGROUNDExpiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis and response to therapy in obstructive lung diseases.To investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases.AIMTo investigate the delta values between expiratory and inspiratory resistance and reactance, measured using respiratory oscillometry and its correlation with air trapping and symptoms in subjects with obstructive lung diseases.Four hundred and seventy-one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered.METHODSFour hundred and seventy-one subjects (96 with chronic obstructive pulmonary disease [COPD], 311 with asthma, 30 healthy smokers and 34 healthy subjects) were included. Spirometry, body plethysmography and respiratory oscillometry measurements were performed and the differences between the expiratory and inspiratory respiratory oscillometry values (as delta values) were calculated. Questionnaires regarding symptoms and quality of life were administered.Patients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5-R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5-R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = -0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms.RESULTSPatients with COPD and healthy smokers had an increased delta resistance at 5 Hz (R5) compared with patients with asthma (p < 0.0001 and p = 0.037, respectively) and healthy subjects (p = 0.0004 and p = 0.012, respectively). Patients with COPD also had higher values of ΔR5-R19 than healthy subjects (p = 0.0001) and patients with asthma (p < 0.0001). Delta reactance at 5 Hz (X5) was significantly more impaired in COPD patients than in asthma and healthy subjects (p < 0.0001 for all). There was a correlation between the ratio of residual volume and total lung capacity and ΔR5 (p = 0.0047; r = 0.32), ΔR5-R19 (p = 0.0002; r = 0.41) and ΔX5 (p < 0.0001; r = -0.44), for all subjects. ΔX5 correlated with symptoms in COPD, healthy smokers and patients with asthma. In addition, ΔR5 correlated with asthma symptoms.EFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.CONCLUSIONEFL was most prominent in parameters measuring peripheral resistance and reactance and correlated with air trapping and airway symptoms.
Author Jarenbäck, Linnea
Tunsäter, Alf
Nasr, Abir
Tufvesson, Ellen
Ankerst, Jaro
Romberg, Kerstin
Bjermer, Leif
Papapostolou, Georgia
Author_xml – sequence: 1
  givenname: Abir
  orcidid: 0009-0000-4961-4183
  surname: Nasr
  fullname: Nasr, Abir
  organization: Lund University
– sequence: 2
  givenname: Georgia
  surname: Papapostolou
  fullname: Papapostolou, Georgia
  organization: Lund University
– sequence: 3
  givenname: Linnea
  surname: Jarenbäck
  fullname: Jarenbäck, Linnea
  organization: Lund University
– sequence: 4
  givenname: Kerstin
  surname: Romberg
  fullname: Romberg, Kerstin
  organization: Health Care Centre, Näsets läkargrupp
– sequence: 5
  givenname: Alf
  surname: Tunsäter
  fullname: Tunsäter, Alf
  organization: Lund University
– sequence: 6
  givenname: Jaro
  surname: Ankerst
  fullname: Ankerst, Jaro
  organization: Lund University
– sequence: 7
  givenname: Leif
  surname: Bjermer
  fullname: Bjermer, Leif
  organization: Lund University
– sequence: 8
  givenname: Ellen
  surname: Tufvesson
  fullname: Tufvesson, Ellen
  email: Ellen.Tufvesson@med.lu.se
  organization: Lund University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38873744$$D View this record in MEDLINE/PubMed
https://lup.lub.lu.se/record/e07f2f28-b5f6-4cbb-83f0-82e353350b84$$DView record from Swedish Publication Index
oai:portal.research.lu.se:publications/e07f2f28-b5f6-4cbb-83f0-82e353350b84$$DView record from Swedish Publication Index
BookMark eNqNkt-K1DAUxoOsuH_0wheQgjd6MbtJk0zaSxl2VRjQCwXvwml6olnSpiat47yGT2xmOlYQFgyE5HB--b6c5FySsz70SMhzRq9ZHjdmsNesrGr5iFwwoeSK1urL2bJfs3NymdI9pUxxoZ6Qc15ViishLsiv25-DizCGuC-gbwvXpyWOmFwaoTd4TEUEM0c2hu6QXciQjPM-dDjmoEXretd_LfCvtPVhV3jXuRFGF_psU4QmjXEyo_uBhZ8y3rqEkDA9JY8t-ITPTusV-Xx3-2nzbrX98Pb95s12ZSTNdYHhlFmDpRDAUHEpIDu3FqxlxhjgRpmyEbTmgtcgmRQUaw5WWEDetsCvCMy6aYfD1Oghug7iXgdweghxBK9zjQjRfNN-0gl1prwzxwqSRqpsactKN9KutTBNoytuqa5K5JJzSZtKZI_tgx5-GvJsTtr_Kfdqlhti-D5hGnXnkkHvoccwJc3pulIyf67K6Mt_0PswxT4_qOaMCUZlTQ-CL07U1HTYLvf70yAZeD0DJoaUItoFYVQfmk_n5tPH5svszczunMf9w6DefLybT_wGFGvhAw
Cites_doi 10.1186/1471-2466-14-23
10.1183/09031936.00038006
10.1183/13993003.01270-2016
10.1186/1477-7525-3-9
10.1155/2013/749860
10.1136/bmjresp-2021-001163
10.1183/09031936.95.08101812
10.1016/j.rmed.2004.10.008
10.1183/09031936.05.00132404
10.1371/journal.pone.0139102
10.1183/23120541.00680-2021
10.1136/thorax.56.11.851
10.1155/2012/234145
10.1259/bjr.20220630
10.1183/23120541.00160-2019
10.2147/COPD.S173686
10.1016/j.jaci.2003.09.008
10.1016/j.resp.2005.05.026
10.1038/s41598-019-48039-x
10.2147/COPD.S137865
10.1016/j.rmed.2012.04.010
10.1183/09031936.03.00089403
10.1164/rccm.201908-1590ST
10.3390/jcm9092778
10.1097/RLI.0b013e31816901ab
10.1034/j.1399-3003.1999.14a08.x
10.1016/j.rmed.2020.105952
10.1155/2013/782052
10.1183/09031936.00102509
10.1080/20018525.2020.1736934
10.2147/COPD.S78332
10.1007/s10877-017-0050-y
10.1183/16000617.0208-2021
10.1183/09031936.00080312
10.1016/j.resp.2017.01.016
10.1183/09031936.04.00131804
10.1053/rmed.2002.1371
10.1186/s12890-023-02777-x
10.1183/09031936.04.00046804
10.1183/09031936.00126212
10.1034/j.1600-0455.2003.00105.x
10.1136/thx.2009.120790
10.1152/japplphysiol.00205.2003
10.1378/chest.10-1210
10.1164/rccm.201701-0218PP
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.
2024 The Author(s). Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.
2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.
– notice: 2024 The Author(s). Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor Clinical Respiratory Medicine
Klinisk lungmedicin
Section V
Neonatology
Respiratory Medicine, Allergology, and Palliative Medicine
Obstetrics and Gynaecology (Lund)
Department of Clinical Sciences, Lund
Strategiska forskningsområden (SFO)
Obstetrik och gynekologi, Lund
Neonatologi
Medicinska fakulteten
Tornbladinstitutet
Medicin/akutsjukvård, Lund
Pediatrik, Lund
Lungfysiologi och biomarkörer
Institutionen för kliniska vetenskaper, Lund
Sektion II
Section II
Lunds universitet
Profile areas and other strong research environments
Lund University
Sektion V
Medicine/Emergency Medicine, Lund
EpiHealth: Epidemiology for Health
Lungmedicin, allergologi och palliativ medicin
Faculty of Medicine
Strategic research areas (SRA)
Paediatrics (Lund)
Tornblad Institute
Lung physiology and biomarkers
Profilområden och andra starka forskningsmiljöer
CorporateAuthor_xml – name: Lungmedicin, allergologi och palliativ medicin
– name: Lungfysiologi och biomarkörer
– name: Strategiska forskningsområden (SFO)
– name: Neonatologi
– name: Section II
– name: EpiHealth: Epidemiology for Health
– name: Strategic research areas (SRA)
– name: Lung physiology and biomarkers
– name: Department of Clinical Sciences, Lund
– name: Obstetrics and Gynaecology (Lund)
– name: Lund University
– name: Respiratory Medicine, Allergology, and Palliative Medicine
– name: Sektion V
– name: Profile areas and other strong research environments
– name: Section V
– name: Medicin/akutsjukvård, Lund
– name: Tornbladinstitutet
– name: Tornblad Institute
– name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Sektion II
– name: Medicine/Emergency Medicine, Lund
– name: Clinical Respiratory Medicine
– name: Institutionen för kliniska vetenskaper, Lund
– name: Klinisk lungmedicin
– name: Lunds universitet
– name: Profilområden och andra starka forskningsmiljöer
– name: Paediatrics (Lund)
– name: Obstetrik och gynekologi, Lund
– name: Pediatrik, Lund
– name: Neonatology
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TS
7U5
8FD
K9.
L7M
7X8
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
DOI 10.1111/cpf.12895
DatabaseName Wiley Online Library Open Access (Activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Physical Education Index
Solid State and Superconductivity Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Advanced Technologies Database with Aerospace
MEDLINE - Academic
SwePub
SWEPUB Lunds universitet full text
SwePub Articles
SWEPUB Freely available online
SWEPUB Lunds universitet
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Solid State and Superconductivity Abstracts
Technology Research Database
Calcium & Calcified Tissue Abstracts
Advanced Technologies Database with Aerospace
Physical Education Index
MEDLINE - Academic
DatabaseTitleList

MEDLINE

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley-Blackwell Open Access Collection
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1475-097X
EndPage 435
ExternalDocumentID oai_portal_research_lu_se_publications_e07f2f28_b5f6_4cbb_83f0_82e353350b84
oai_lup_lub_lu_se_e07f2f28_b5f6_4cbb_83f0_82e353350b84
38873744
10_1111_cpf_12895
CPF12895
Genre article
Journal Article
Comparative Study
GrantInformation_xml – fundername: Interreg
  funderid: ÖKS [NYPS20201002]
– fundername: Hjärt‐Lungfonden
– fundername: Hjärt-Lungfonden
– fundername: Interreg
  grantid: ÖKS [NYPS20201002]
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
24P
29B
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
TEORI
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
1OB
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TS
7U5
8FD
K9.
L7M
7X8
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
ID FETCH-LOGICAL-c5075-ac301fce244a1e7354adefdfaff1ccca3c7c2b4093439a51540e93af4fae3dda3
IEDL.DBID 24P
ISSN 1475-0961
1475-097X
IngestDate Wed Aug 27 03:59:14 EDT 2025
Thu Jul 03 04:40:38 EDT 2025
Fri Jul 11 10:20:05 EDT 2025
Sat Jul 26 00:39:07 EDT 2025
Tue Aug 05 11:42:41 EDT 2025
Tue Jul 01 01:42:48 EDT 2025
Wed Jan 22 17:16:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords airway obstruction
airflow limitation
smoker
asthma
COPD
Language English
License Attribution-NonCommercial
2024 The Author(s). Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5075-ac301fce244a1e7354adefdfaff1ccca3c7c2b4093439a51540e93af4fae3dda3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0000-4961-4183
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcpf.12895
PMID 38873744
PQID 3114105904
PQPubID 1006519
PageCount 10
ParticipantIDs swepub_primary_oai_portal_research_lu_se_publications_e07f2f28_b5f6_4cbb_83f0_82e353350b84
swepub_primary_oai_lup_lub_lu_se_e07f2f28_b5f6_4cbb_83f0_82e353350b84
proquest_miscellaneous_3068758877
proquest_journals_3114105904
pubmed_primary_38873744
crossref_primary_10_1111_cpf_12895
wiley_primary_10_1111_cpf_12895_CPF12895
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2024
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Clinical physiology and functional imaging
PublicationTitleAlternate Clin Physiol Funct Imaging
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2023; 96
2019; 9
2012; 2012
2011; 139
2019; 5
2002; 96
2017; 49
2004; 23
2013; 42
2015; 10
2017; 195
2003; 95
2012; 106
2019; 200
1995; 8
2005; 25
2017; 239
2009; 34
2020; 7
2010; 65
2023; 23
2004; 113
2013; 2013
2020; 170
2022; 8
2005; 148
2022; 9
2020; 9
2017; 12
1999; 14
2019
2006; 29
2014; 14
2008; 43
2022; 31
2005; 3
2001; 56
2018; 32
2005; 99
2003; 22
2003; 44
2012; 40
2018; 13
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_42_1
e_1_2_9_20_1
e_1_2_9_40_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 96
  issue: 1146
  year: 2023
  article-title: MR imaging of the airways
  publication-title: The British Journal of Radiology
– volume: 34
  start-page: 648
  issue: 3
  year: 2009
  end-page: 654
  article-title: Development and first validation of the COPD Assessment Test
  publication-title: European Respiratory Journal
– volume: 23
  start-page: 187
  issue: 2
  year: 2004
  end-page: 188
  article-title: Assessment of expiratory flow limitation in chronic obstructive pulmonary disease: a new approach
  publication-title: European Respiratory Journal
– volume: 44
  start-page: 517
  issue: 5
  year: 2003
  end-page: 524
  article-title: Value of air trapping in detection of small airways disease in smokers
  publication-title: Acta Radiologica
– volume: 23
  start-page: 477
  issue: 1
  year: 2023
  article-title: Using intra‐breath oscillometry in obesity hypoventilation syndrome to detect tidal expiratory flow limitation: a potential marker to optimize CPAP therapy
  publication-title: BMC Pulmonary Medicine
– volume: 29
  start-page: 363
  issue: 2
  year: 2006
  end-page: 374
  article-title: Expiratory flow limitation detected by forced oscillation and negative expiratory pressure
  publication-title: European Respiratory Journal
– volume: 200
  start-page: e70
  year: 2019
  end-page: e88
  article-title: Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement
  publication-title: American Journal of Respiratory and Critical Care Medicine
– volume: 5
  issue: 4
  year: 2019
  article-title: Comparison of oscillometry devices using active mechanical test loads
  publication-title: ERJ Open Research
– volume: 40
  start-page: 1324
  issue: 6
  year: 2012
  end-page: 1343
  article-title: Multi‐ethnic reference values for spirometry for the 3‐95‐yr age range: the global lung function 2012 equations
  publication-title: The European Respiratory Journal
– volume: 2013
  start-page: 1
  year: 2013
  end-page: 6
  article-title: Expiratory flow limitation definition, mechanisms, methods, and significance
  publication-title: Pulmonary Medicine
– volume: 7
  issue: 1
  year: 2020
  article-title: Clinical characteristics of the BREATHE cohort—a real‐life study on patients with asthma and COPD
  publication-title: European Clinical Respiratory Journal
– volume: 170
  year: 2020
  article-title: Current place of impulse oscillometry in the assessment of pulmonary diseases
  publication-title: Respiratory Medicine
– volume: 10
  issue: 10
  year: 2015
  article-title: Quantification of pathologic air trapping in lung transplant patients using CT density mapping: comparison with other CT air trapping measures
  publication-title: PLoS One
– volume: 8
  start-page: 1812
  issue: 10
  year: 1995
  end-page: 1813
  article-title: RV/TLC% ratio: alternative criteria of normality
  publication-title: European Respiratory Journal
– volume: 9
  issue: 1
  year: 2019
  article-title: Oscillometry in chronic obstructive lung disease: in vitro and in vivo evaluation of the impulse oscillometry and tremoflo devices
  publication-title: Scientific Reports
– volume: 42
  start-page: 1513
  issue: 6
  year: 2013
  end-page: 1523
  article-title: Respiratory impedance in healthy subjects: baseline values and bronchodilator response
  publication-title: European Respiratory Journal
– volume: 25
  start-page: 986
  issue: 6
  year: 2005
  end-page: 991
  article-title: Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma
  publication-title: European Respiratory Journal
– volume: 13
  start-page: 3281
  year: 2018
  end-page: 3295
  article-title: Forced oscillation technique for early detection of the effects of smoking and COPD: contribution of fractional‐order modeling
  publication-title: International Journal of Chronic Obstructive Pulmonary Disease
– volume: 195
  start-page: 557
  issue: 5
  year: 2017
  end-page: 582
  article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
  publication-title: American Journal of Respiratory and Critical Care Medicine
– volume: 9
  issue: 1
  year: 2022
  article-title: Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis
  publication-title: BMJ Open Respiratory Research
– volume: 148
  start-page: 179
  issue: 1–2
  year: 2005
  end-page: 194
  article-title: Clinical applications of forced oscillation to assess peripheral airway function
  publication-title: Respiratory Physiology & Neurobiology
– volume: 10
  start-page: 939
  year: 2015
  end-page: 945
  article-title: Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission
  publication-title: International Journal of Chronic Obstructive Pulmonary Disease
– volume: 31
  issue: 163
  year: 2022
  article-title: Clinical significance and applications of oscillometry
  publication-title: European Respiratory Review
– volume: 106
  start-page: 1116
  issue: 8
  year: 2012
  end-page: 1123
  article-title: Impulse oscillometry may be of value in detecting early manifestations of COPD
  publication-title: Respiratory Medicine
– volume: 2013
  year: 2013
  article-title: Flow‐volume parameters in COPD related to extended measurements of lung volume, diffusion, and resistance
  publication-title: Pulmonary Medicine
– volume: 239
  start-page: 41
  year: 2017
  end-page: 45
  article-title: The relationship between respiratory system impedance and lung function in asthmatics: a prospective observational study
  publication-title: Respiratory Physiology & Neurobiology
– volume: 49
  issue: 2
  year: 2017
  article-title: Airway dynamics in COPD patients by within‐breath impedance tracking: effects of continuous positive airway pressure
  publication-title: European Respiratory Journal
– volume: 8
  issue: 2
  year: 2022
  article-title: Expiratory flow limitation in a cohort of highly symptomatic COPD patients
  publication-title: ERJ Open Research
– volume: 32
  start-page: 509
  issue: 3
  year: 2018
  end-page: 512
  article-title: Discrepancy between in vivo and in vitro comparisons of forced oscillation devices
  publication-title: Journal of Clinical Monitoring and Computing
– volume: 95
  start-page: 854
  issue: 2
  year: 2003
  end-page: 862
  article-title: Invited review: understanding airway pathophysiology with computed tomograpy
  publication-title: Journal of Applied Physiology
– volume: 43
  start-page: 403
  issue: 6
  year: 2008
  end-page: 410
  article-title: Quantitatively assessed dynamic contrast‐enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography
  publication-title: Investigative Radiology
– volume: 22
  start-page: 1026
  issue: 6
  year: 2003
  end-page: 1041
  article-title: The forced oscillation technique in clinical practice: methodology, recommendations and future developments
  publication-title: European Respiratory Journal
– volume: 14
  start-page: 32
  issue: 1
  year: 1999
  end-page: 38
  article-title: Development and validation of the Mini Asthma Quality of Life Questionnaire
  publication-title: European Respiratory Journal
– volume: 14
  start-page: 23
  year: 2014
  article-title: Predictors of expiratory flow limitation measured by forced oscillation technique in COPD
  publication-title: BMC Pulmonary Medicine
– volume: 65
  start-page: 263
  issue: 3
  year: 2010
  end-page: 267
  article-title: Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease
  publication-title: Thorax
– volume: 3
  start-page: 9
  year: 2005
  article-title: Validation of the Clinical COPD questionnaire in Italian language
  publication-title: Health and Quality of Life Outcomes
– volume: 12
  start-page: 1503
  year: 2017
  end-page: 1506
  article-title: Clinical characteristics of COPD patients with tidal expiratory flow limitation
  publication-title: International Journal of Chronic Obstructive Pulmonary Disease
– volume: 23
  start-page: 232
  issue: 2
  year: 2004
  end-page: 240
  article-title: Detection of expiratory flow limitation in COPD using the forced oscillation technique
  publication-title: European Respiratory Journal
– volume: 2012
  start-page: 1
  year: 2012
  end-page: 8
  article-title: Methods for assessing expiratory flow limitation during tidal breathing in COPD patients
  publication-title: Pulmonary Medicine
– volume: 56
  start-page: 851
  issue: 11
  year: 2001
  end-page: 856
  article-title: Influence of age and disease severity on high resolution CT lung densitometry in asthma
  publication-title: Thorax
– volume: 9
  start-page: 2778
  issue: 9
  year: 2020
  article-title: Clinical application of forced oscillation technique (FOT) in early detection of airway changes in smokers
  publication-title: Journal of Clinical Medicine
– year: 2019
– volume: 96
  start-page: 934
  issue: 11
  year: 2002
  end-page: 943
  article-title: Relationship between lung function, ventilation‐perfusion inequality and extent of emphysema as assessed by high‐resolution computed tomography
  publication-title: Respiratory Medicine
– volume: 99
  start-page: 553
  issue: 5
  year: 2005
  end-page: 558
  article-title: Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
  publication-title: Respiratory Medicine
– volume: 113
  start-page: 59
  issue: 1
  year: 2004
  end-page: 65
  article-title: Development of the asthma control test: a survey for assessing asthma control
  publication-title: Journal of Allergy and Clinical Immunology
– volume: 139
  start-page: 412
  issue: 2
  year: 2011
  end-page: 423
  article-title: Small airway disease in asthma and COPD
  publication-title: Chest
– ident: e_1_2_9_33_1
  doi: 10.1186/1471-2466-14-23
– ident: e_1_2_9_14_1
  doi: 10.1183/09031936.00038006
– ident: e_1_2_9_31_1
  doi: 10.1183/13993003.01270-2016
– ident: e_1_2_9_11_1
  doi: 10.1186/1477-7525-3-9
– ident: e_1_2_9_43_1
  doi: 10.1155/2013/749860
– ident: e_1_2_9_46_1
  doi: 10.1136/bmjresp-2021-001163
– ident: e_1_2_9_16_1
  doi: 10.1183/09031936.95.08101812
– ident: e_1_2_9_27_1
  doi: 10.1016/j.rmed.2004.10.008
– ident: e_1_2_9_7_1
  doi: 10.1183/09031936.05.00132404
– ident: e_1_2_9_42_1
  doi: 10.1371/journal.pone.0139102
– ident: e_1_2_9_5_1
  doi: 10.1183/23120541.00680-2021
– ident: e_1_2_9_34_1
  doi: 10.1136/thorax.56.11.851
– ident: e_1_2_9_30_1
  doi: 10.1155/2012/234145
– ident: e_1_2_9_9_1
  doi: 10.1259/bjr.20220630
– ident: e_1_2_9_12_1
  doi: 10.1183/23120541.00160-2019
– ident: e_1_2_9_40_1
  doi: 10.2147/COPD.S173686
– ident: e_1_2_9_35_1
  doi: 10.1016/j.jaci.2003.09.008
– ident: e_1_2_9_20_1
  doi: 10.1016/j.resp.2005.05.026
– ident: e_1_2_9_32_1
  doi: 10.1038/s41598-019-48039-x
– ident: e_1_2_9_13_1
  doi: 10.2147/COPD.S137865
– ident: e_1_2_9_18_1
  doi: 10.1016/j.rmed.2012.04.010
– ident: e_1_2_9_19_1
– ident: e_1_2_9_37_1
  doi: 10.1183/09031936.03.00089403
– ident: e_1_2_9_21_1
  doi: 10.1164/rccm.201908-1590ST
– ident: e_1_2_9_8_1
  doi: 10.3390/jcm9092778
– ident: e_1_2_9_22_1
  doi: 10.1097/RLI.0b013e31816901ab
– ident: e_1_2_9_26_1
  doi: 10.1034/j.1399-3003.1999.14a08.x
– ident: e_1_2_9_4_1
  doi: 10.1016/j.rmed.2020.105952
– ident: e_1_2_9_23_1
  doi: 10.1155/2013/782052
– ident: e_1_2_9_25_1
  doi: 10.1183/09031936.00102509
– ident: e_1_2_9_2_1
  doi: 10.1080/20018525.2020.1736934
– ident: e_1_2_9_24_1
  doi: 10.2147/COPD.S78332
– ident: e_1_2_9_47_1
  doi: 10.1007/s10877-017-0050-y
– ident: e_1_2_9_29_1
  doi: 10.1183/16000617.0208-2021
– ident: e_1_2_9_39_1
  doi: 10.1183/09031936.00080312
– ident: e_1_2_9_28_1
  doi: 10.1016/j.resp.2017.01.016
– ident: e_1_2_9_17_1
  doi: 10.1183/09031936.04.00131804
– ident: e_1_2_9_41_1
  doi: 10.1053/rmed.2002.1371
– ident: e_1_2_9_3_1
  doi: 10.1186/s12890-023-02777-x
– ident: e_1_2_9_15_1
  doi: 10.1183/09031936.04.00046804
– ident: e_1_2_9_36_1
  doi: 10.1183/09031936.00126212
– ident: e_1_2_9_44_1
  doi: 10.1034/j.1600-0455.2003.00105.x
– ident: e_1_2_9_38_1
  doi: 10.1136/thx.2009.120790
– ident: e_1_2_9_10_1
  doi: 10.1152/japplphysiol.00205.2003
– ident: e_1_2_9_6_1
  doi: 10.1378/chest.10-1210
– ident: e_1_2_9_45_1
  doi: 10.1164/rccm.201701-0218PP
SSID ssj0017347
Score 2.4038098
Snippet Background Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status,...
Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status,...
BackgroundExpiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status,...
Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status, prognosis...
Background: Expiratory flow limitation (EFL) during tidal breathing and lung hyperinflation have been identified as major decisive factors for disease status,...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 426
SubjectTerms Adult
Aged
airflow limitation
airway obstruction
Airway Resistance
Asthma
Asthma - diagnosis
Asthma - physiopathology
Case-Control Studies
Chronic obstructive pulmonary disease
Clinical Medicine
COPD
Correlation
Disease resistance
Exhalation
Female
Flow resistance
Forced Expiratory Volume
Humans
Inhalation
Klinisk medicin
Lung - physiopathology
Lung diseases
Lungmedicin och allergi
Male
Medical and Health Sciences
Medicin och hälsovetenskap
Middle Aged
Oscillometry - methods
Plethysmography
Plethysmography, Whole Body - methods
Predictive Value of Tests
Pulmonary Disease, Chronic Obstructive - diagnosis
Pulmonary Disease, Chronic Obstructive - physiopathology
Quality of Life
Reactance
Respiratory Medicine and Allergy
Signs and symptoms
smoker
Smoking
Smoking - adverse effects
Smoking - physiopathology
Spirometry - methods
Surveys and Questionnaires
Trapping
Title Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcpf.12895
https://www.ncbi.nlm.nih.gov/pubmed/38873744
https://www.proquest.com/docview/3114105904
https://www.proquest.com/docview/3068758877
https://lup.lub.lu.se/record/e07f2f28-b5f6-4cbb-83f0-82e353350b84
oai:portal.research.lu.se:publications/e07f2f28-b5f6-4cbb-83f0-82e353350b84
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3daxQxEA-1gvhS6mevrRLFB19Wckn2sotPUu8oQqWIheJLyMcEhXX34Frt3-Ff7CSbjS0q9GGP20t2cuwvk_xmZ2eGkFeoX7GmLVStN7yK6VtQ51peAbeggm89dzHA-eTj4vhMfjivz7fI2ykWZswPUR64Rc1I63VUcGM315TcrcMbXFzb-g65G0Nr4yTn8rS4EJRI1cXmUtVVrGuS0wrF13jKpTc3o78YZkkfepO5pq1ntUt2Mmek70aQH5At6B-SeyfZK_6I_FpeTe5yanpPv_XFfU7Rmo4MEaFNTUgR3XgW40pia-kZs1p23fAdLvDEQ0iVIyj8ER264SftYkBUQhOHoYPN-Wd_AO1w2aDZ37N5TM5Wy89Hx1WutVA5ZIR1ZRxqenCAu72ZgxK1NDiSDyaEuUOUhVOOWzQGBTIYgyRIMmiFCTIYEN4b8YRs90MPe4RiX98sBNi2CTLan4pJYKEOCytr0bIZeTnddL0eU2royRRBZHRCZkYOJzh01qqNFvP0VmrL5Iy8KM2oD9HJYXoYLrEPW6AJhkunmpGnI4xlFIE_CyXx6uWIa2mJSba7yzUeFg-9AQ1MBR54oy3-cS2dtboRgemGg0CKXDPboJwv_5Az2k06J2v6muWtrz2FvaXw12nO_f8e6aPTVfqyf_uuB-Q-R1o2RlMekm2cJPAMadWFfZ7UBz_ff-K_AUATJLQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVKkYAL4puFAgZx4BLktZ04kbigalcLdKseWqniYtnOWCCFZKVtgd_BL2bsOKYVIPUQaRM741Umz37jycwQ8hrxFWraQtG0hhchfQtiruEFcAvKt03LXQhwXh9WqxP58bQ83SHvpliYMT9E3nALyIjzdQB42JC-gHK38W9xdm3Ka-S6rLgKhRu4PMo-BCViebG5VGURCpukvELhO5586-XV6C-KmfOHXqauce1Z3iG3E2mk70ct3yU70N8jN9bJLX6f_Fr8nPzl1PQt_dpn_zlFczpQRNRtbEKO6MazEFgSWnPPkNay64ZvcIYnLfhYOoLCH9G-G37QLkRERXXiMHSwKQHtd6Adzhs0OXy2D8jJcnG8vypSsYXCISUsC-MQ6t4BLvdmDkqU0uBIrTfezx2qWTjluEVrUCCFMciCJINGGC-9AdG2Rjwku_3Qw2NCsW9bVwJsU3sZDFDFJDBf-srKUjRsRl5ND11vxpwaerJFUDM6amZG9iZ16ASrrRbz-Flqw-SMvMzNCIjg5TA9DOfYh1Vog-HcqWbk0ajGPIrAy0JJvHsx6jW3hCzb3fkGD4uH3oIGpjz3vNYW_7iWzlpdC890zUEgRy6ZrVHO53_IGQ0nnbI1fUnyNhe2Ya8o_E185_7_jPT-0TL-eHL1ri_IzdXx-kAffDj89JTc4sjRxtDKPbKLLww8Q451Zp9HKP0GEMEnNw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKkSouiDdbChjEgUtQ1nbWiTihsqvyaLUHKlVcLD_GKlJIIm1b-B38YsaOY1oBUg-RNrEzXmX82d9kMjOEvEJ8hZq2UDROsyKkb0HMNawAZkB61zhmQ4Dz4dHi4Fh8PKlOtsjbKRZmzA-RX7gFZMT1OgB8cP4SyO3g3-Di2lQ3yM3g7AvTm4l1diFIHquLzYWsilDXJKUVCp_x5FuvbkZ_McycPvQqc41bz-oOuZ04I303Kvku2YLuHtk5TF7x--TX8ufkLqe6c_Rbl93nFK3pwBBRtbEJKaIdz0JcSWjNPUNWy7btv8MZnjjwsXIEhT-ifdv_oG0IiIraxGFob1L-2QugLS4bNPl7Ng_I8Wr5Zf-gSLUWCouMsCq0RaR7C7jb6zlIXgmNIzmvvZ9b1DK30jKDxiBHBqORBIkSGq698Bq4c5o_JNtd38FjQrGvqxccTFN7EexPWQoofeUXRlS8KWfk5fTQ1TCm1FCTKYKaUVEzM7I3qUMlVG0Un8evUptSzMiL3Ix4CE4O3UF_jn3KBZpguHTKGXk0qjGPwvEylwLvXo56zS0hyXZ7PuBh8FAbUFBKzzyrlcE_roQ1RtXcl6pmwJEiV6WpUc7Xf8gZ7SaVkjWdJnnDpbew1xT-Os65_z8jtb9exR-71-_6nOys36_U5w9Hn56QWwwZ2hhYuUe2cb7AU2RYZ-ZZRNJvQLsmaQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expiratory+and+inspiratory+resistance+and+reactance+from+respiratory+oscillometry+defining+expiratory+flow+limitation+in+obstructive+lung+diseases&rft.jtitle=Clinical+physiology+and+functional+imaging&rft.au=Nasr%2C+Abir&rft.au=Papapostolou%2C+Georgia&rft.au=Jarenb%C3%A4ck%2C+Linnea&rft.au=Romberg%2C+Kerstin&rft.date=2024-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1475-0961&rft.eissn=1475-097X&rft.volume=44&rft.issue=6&rft.spage=426&rft.epage=435&rft_id=info:doi/10.1111%2Fcpf.12895&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-0961&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-0961&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-0961&client=summon